Atlas Trials

Satisfaction Regarding the Dispensing of Emicizumab (HEMLIBRA®) for Patients With Haemophilia A in France

Clinical trial NCT05450640 · COMPLETED

Trial details

NCT number
NCT05450640
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Study type
OBSERVATIONAL
Hemophilia A
Start date
2023-01-09
Primary completion
2023-01-09
Enrollment
176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.